BACE1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.12429987331586E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.08519999999046E-05 |
Normal-vs-Stage2 |
2.3263999948675E-08 |
Normal-vs-Stage3 |
8.91969997862674E-09 |
Normal-vs-Stage4 |
3.35139999974032E-07 |
Stage1-vs-Stage2 |
5.184800E-03 |
Stage1-vs-Stage3 |
1.311920E-02 |
Stage1-vs-Stage4 |
1.188380E-02 |
Stage2-vs-Stage3 |
4.020200E-01 |
Stage2-vs-Stage4 |
8.899200E-01 |
Stage3-vs-Stage4 |
5.150000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.09800002423555E-09 |
Normal-vs-AfricanAmerican |
1.988140E-04 |
Normal-vs-Asian |
3.727800E-01 |
Caucasian-vs-AfricanAmerican |
5.667000E-01 |
Caucasian-vs-Asian |
5.227000E-01 |
AfricanAmerican-vs-Asian |
4.688600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.29959973075245E-10 |
Normal-vs-Female |
3.40419999966812E-07 |
Male-vs-Female |
3.957400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.124400E-01 |
Normal-vs-Age(41-60Yrs) |
1.11260000001945E-06 |
Normal-vs-Age(61-80Yrs) |
7.01899649513393E-11 |
Normal-vs-Age(81-100Yrs) |
2.793500E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.038200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.967900E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.523900E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.380100E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.165800E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.985200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.136200E-01 |
Normal-vs-Grade 2 |
1.6223599999976E-05 |
Normal-vs-Grade 3 |
2.63049582116537E-11 |
Normal-vs-Grade 4 |
3.90019999996216E-06 |
Grade 1-vs-Grade 2 |
7.881700E-02 |
Grade 1-vs-Grade 3 |
5.055700E-03 |
Grade 1-vs-Grade 4 |
2.739800E-02 |
Grade 2-vs-Grade 3 |
6.316300E-03 |
Grade 2-vs-Grade 4 |
5.994000E-02 |
Grade 3-vs-Grade 4 |
7.965400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.72159999589638E-08 |
Normal-vs-ccB subtype |
5.164600E-04 |
ccA subtype-vs-ccB subtype |
1.671410E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.91380000022801E-08 |
Normal-vs-N1 |
1.041770E-02 |
N0-vs-N1 |
2.479600E-01 |
|
|